Follicular lymphoma in children and adolescents: clinical, diagnostic and therapeutic features

   Ffollicular lymphoma (FL) is one of the most common non-Hodgkin’s lymphomas in adults, while it is a diagnosis of exclusion in adolescents and children. Clinical manifestations of FL in children are represented by long-term asymptomatic lymphadenopathy, less commonly by extranodal areas involvement. treatment standards for FL in children have not been developed and may vary from observational tactics (with the radical resection of a single focus during a biopsy) to the use of radiation therapy and polychemotherapy. Pediatric type follicular lymphoma was first identified as a distinct variant in 2008 in the world Health organization classification of hematopoietic and lymphoid tissue tumors. Clinical, morphological (cytological type 3A), Immunohistochemical (absence of bcl2 expression in the center of the follicle) and cytogenetic (absence of t(14;18)(q32;q21)) features served as the reason for separation into an independent nosological variant. Despite the term “pediatric”, cases of pediatric type FL have been described in adults over 30 years of age. Most often, the disease is diagnosed in the early stages (I, II) and is characterized by a favorable prognosis. In children and adolescents, FL occurs not only of the pediatric type. we present a clinical case of a typical “adult” type FL (grade 1–2) in a 17-year-old patient. the cHop therapy (cyclophosphamide, doxorubicin, vincristine, and prednisolone) with rituximab resulted in a complete remission, which lasted more than 2.5 years.

1. Liu Q., Salaverria I., Pittaluga S. et al. Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma. Am J Surg Pathol 2013;37(3): 333–43. DOI: 10.1097/PAS.0b013e31826b9b57

2. Green M.R. Chromatin modifying gene mutations in follicular lymphoma. Blood 2018;131(6):595–604. DOI: 10.1182/blood-2017-08-737361

3. Tumyan G.S. Follicular lymphoma: current trends and my choice. Klinicheskaya onkogematologiya = Clinical Oncohematology 2013;6(1):20–33. (In Russ.).

4. Tumyan G.S., Leontieva A.A., Falaleeva N.A. et al. Follicular lymphoma: 10 years of therapy. Klinicheskaya onkogematologiya = Clinical Oncohematology 2012;(3). (In Russ.).

5. Fischer T., Zing N.P.C., Chiattone C.S. et al. Transformed follicular lymphoma. Ann Hematol 2018;97(1):17–29. DOI: 10.1007/s00277-017-3151-2

6. Kovrigina A.M., Plastinina L.V., Kravchenko S.K. et al. Diagnosis of pediatric type follicular lymphoma in young adults (own data). Klinicheskaya onkogematologiya = Clinical Oncohematology 2017;10(1):52–60. (In Russ.).

7. Pugh T.J., Ballonoff A., Newman F., Rabinovitch R. Improved survival in patients with early stage low­grade follicular lymphoma treated with radiation. A Surveillance, Epidemiology, and End Results database analysis. Cancer 2010;116(16):3843–51. DOI: 10.1002/cncr.25149

8. Ardeshna K.M., Smith P., Norton A. et al. Long­-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advancedstage non­Hodgkin lymphoma: a randomised controlled trial. Lancet 2003;362(9383):516–22. DOI: 10.1016/s0140-6736(03)14110-4

9. Subramanian J., Cavenagh J., Desai B., Jacobs I. Rituximab in the treatment of follicular lymphoma: the future of biosimilars in the evolving therapeutic landscape. Cancer Manag Res 2017;9:131–140. DOI: 10.2147/CMAR.S120589

10. Mondello P., Steiner N., Willenbacher W. et al. Bendamustine plus rituximab versus R­CHOP as first­line treatment for patients with follicular lymphoma Grade 3A: evidence from a multicenter, retrospective study. Oncologist 2018;23(4):454–60. DOI: 10.1634/theoncologist.2017-0037

11. Oschlies I., Salaverria I., Mahn F. et al. Pediatric follicular lymphoma – a clinico­pathological study of a population­based series of patients treated within the Non­Hodgkin’s Lymphoma – Berlin–Frankfurt–Munster (NHL­BFM) multicenter trials. Haematologica 2010;95(2):253–9. DOI: 10.3324/haematol.2009.013177

12. Louissaint A.Jr, Schafernak K.T., Geyer J.T. et al. Pediatric­type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations. Blood 2016;128(8):1093–100. DOI: 10.1182/blood-2015-12-682591

13. Attarbaschi A., Beishuizen A., Mann G. et al. European Intergroup for Childhood Non­Hodgkin Lymphoma (EICNHL) and the international Berlin­Frankfurt­Münster (i­BFM) Study Group. Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a “Watch and wait” strategy after complete resection. Ann Hematol 2013;92(11):1537–41. DOI: 10.1007/s00277-013-1785-2

14. Du X.Y., Huang R., Cao L. et al. Clinical observation of five pediatric­type follicular lymphoma in adult. Zhonghua Xue Ye Xue Za Zhi 2019;40(5):393–7. DOI: 10.3760/cma.j.issn.0253-2727.2019.05.009

15. Verma A., Pan Z. Pediatric­type follicular lymphoma. Hum Pathol Rep 2022;27. DOI: 10.1016/j.hpr.2022.300590